Details for Patent: 6,245,911

✉ Email this page to a colleague

Summary for Patent: 6,245,911

Scope and claims summary:

Title:	Donepezil polycrystals and process for producing the same
Abstract:	The present invention provides novel polymorphic crystals (A) to (C) having excellent handling properties and an extremely low content of residual solvent of donepezil used as a precursor for production of donepezil hydrochloride having an excellent action as a medicament, and an industrial process for producing the same. Further, the novel polymorphic crystals (A) to (C) according to the present invention are characterized by the powder X-ray diffraction pattern and/or IR absorption peaks of donepezil represented by the following formula: ##STR1##
Inventor(s):	Imai; Akio (Ibaraki, JP), Ichinohe; Toshiyuki (Ibaraki, JP), Endo; Takashi (Ibaraki, JP), Tsurugi; Tomio (Ibaraki, JP), Uemura; Makoto (Ibaraki, JP)
Assignee:	Eisai Co., Ltd. (Tokyo, JP)
Application Number:	09/555,807
Patent Claim Types: see list of patent claims	Compound; Process;

Drugs Protected by US Patent 6,245,911

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,245,911

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	9-336165	Dec 05, 1997

PCT Information
PCT Filed	December 01, 1998	PCT Application Number:	PCT/JP98/05405
PCT Publication Date:	June 17, 1999	PCT Publication Number:	WO99/29668

International Family Members for US Patent 6,245,911

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	260896	⤷ Subscribe
Germany	69822218	⤷ Subscribe
Denmark	1048653	⤷ Subscribe
European Patent Office	1048653	⤷ Subscribe
Spain	2218869	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.